Who invested in Twist Bioscience

5 rounds we have observed, with the 13 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

B2B

Funding summaryUpdated 26 Oct 2026

$332Mraised across 5 rounds since 2014, from 5 sources

$9.1MSeries A$26MSeries B$10MDebt$37MSeries C$250MRound

Latest round: Round, $250MFeb 2022
Step-upi: 6.8×
Investors: 13

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20142016201820202022

$9.1MSeries A$26MSeries B$37MSeries C$250MRound

First round: Series A, $9.1M
Biggest round: $250M
Usual gap between rounds: 8 months

The rounds

Feb 2022
Round$250M2 new4 returning
Source recorded
Jun 2015
Series C$37M5 new3 returning
From a historical funding recordSEC filing: $37M sold, first sale May 2015
Sept 2014
Debt$10M1 new
- SVB Capital
From a historical funding record
May 2014
Series B$26M4 new1 returning
From a historical funding recordSEC filing: $26M sold, first sale May 2014
Feb 2014
Series A$9.1M1 new
- Asset Management Ventures
From a historical funding recordSEC filing: $9.1M sold, first sale Jul 2013

Founders and team

From Twist Bioscience's own website and the SEC filings it signed: 1 founder, 16 on the team.

Keith Marine CrandellCo-Founder and Managing DirectorNamed on its 2018 Form D

Patrick FinnPresident and Chief Operating Officer
Emily Marine LeproustChief Executive Officer
Jimmy JinSenior Vice President of Product and Marketing
Mark BuckSenior Vice President of Operations
Nicole MorenoSenior Vice President of Sales and Support
Paula GreenSenior Vice President of Human Resources
Bob Marine RagusaCEO
Adam LaponisChief Financial Officer
Dennis ChoChief Legal Officer and Corporate Secretary
Mike FeroChief Information Officer
Siyuan ChenChief Technology Officer
Nelson C. ChanChairman of the Board
Stock Quote ChartAnalyst Coverage
Bill Marine PeckExecutive Officeri
Rob Marine ChessChairman of the Board of Directors
William Marine BanyaiExecutive Officer, Directori

On the board, as filediFred Marine CravesMinqi Marine LiPaul Marine Conley

AdvisersJan Johannessen

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series A2014Series B2014Debt2014Series C2015Round2022

ARCH Venture Partners

Paladin Capital GroupFidelity

Foresite Capital

Asset Management Ventures

Yuri Milner

SVB Capital

Cormorant Asset Management

Illumina Ventures

Venture Investors

Everyone who backed them

ARCH Venture PartnersVC firm3rounds

Paladin Capital GroupVC firm3rounds

FidelityVC firm2rounds

Foresite CapitalPrivate equity2rounds

Asset Management VenturesVC firm2rounds

Yuri MilnerVC firm2rounds

SVB CapitalVC firm1round

Cormorant Asset ManagementPrivate equity1round

Illumina VenturesVC firm1round

Venture InvestorsVC firm1round

IlluminaCompany1round

Tao Venture PartnersGrowth equity1round

Joby PritzkerAngel1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 4 firms list Twist Bioscience as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

LionBirdVC firmPer its own site

SpearheadVC firmPer its own site

NanoDimensionVC firmPer its own site

Prime PartnersVC firmPer its own site

Quick answers about Twist Bioscience

Who invested in Twist Bioscience?

Twist Bioscience's investors include ARCH Venture Partners, Paladin Capital Group, Fidelity, Foresite Capital and Asset Management Ventures, and 8 more on record.